The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126046462 12604646 2 F 20160719 20160727 20160728 20160729 EXP CZ-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-47571CZ BOEHRINGER INGELHEIM 92.00 YR M Y 0.00000 20160729 MD CZ CZ

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126046462 12604646 1 PS PRADAXA DABIGATRAN ETEXILATE MESYLATE 1 Oral 22512 CAPSULE
126046462 12604646 2 SS PRADAXA DABIGATRAN ETEXILATE MESYLATE 1 22512
126046462 12604646 3 C BETADINE POVIDONE-IODINE 1 Unknown 0 ORAL SOLUTION
126046462 12604646 4 C CAVINTON VINPOCETINE 1 Oral 10 MG 0 5 MG TABLET BID
126046462 12604646 5 C DIAZEPAM. DIAZEPAM 1 Oral 5 MG 0 5 MG TABLET QD
126046462 12604646 6 C DIGOXIN. DIGOXIN 1 Oral 0.0625 MG 0 .125 MG TABLET QOD
126046462 12604646 7 C ERCEFURYL NIFUROXAZIDE 1 Oral 600 MG 0 200 MG CAPSULE TID
126046462 12604646 8 C FENTANYL. FENTANYL 1 Unknown PATCH/FENTANYL; DOSE PER APPLICATION 50 MCG/HR 3/4 OF PLASTER 0 TRANSDERMAL PATCH
126046462 12604646 9 C HEPAROID 2 Unknown 0 CREAM
126046462 12604646 10 C LOMAC OMEPRAZOLE 1 Oral 20 MG 0 20 MG CAPSULE QD
126046462 12604646 11 C MIRZATEN MIRTAZAPINE 1 Oral 15 MG 0 15 MG TABLET QD
126046462 12604646 12 C NITROGLYCERIN. NITROGLYCERIN 1 Sublingual 0 TABLET
126046462 12604646 13 C OMNIC TAMSULOSIN HYDROCHLORIDE 1 Oral 0.4 MG 0 .4 MG TABLET QD
126046462 12604646 14 C PRONTODERM 2 Nasal NASAL GEL 0 GEL TID

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126046462 12604646 1 Cerebrovascular accident prophylaxis
126046462 12604646 2 Atrial fibrillation
126046462 12604646 3 Product used for unknown indication
126046462 12604646 4 Product used for unknown indication
126046462 12604646 5 Product used for unknown indication
126046462 12604646 6 Product used for unknown indication
126046462 12604646 7 Product used for unknown indication
126046462 12604646 8 Product used for unknown indication
126046462 12604646 9 Product used for unknown indication
126046462 12604646 10 Product used for unknown indication
126046462 12604646 11 Product used for unknown indication
126046462 12604646 12 Product used for unknown indication
126046462 12604646 13 Product used for unknown indication
126046462 12604646 14 Infection prophylaxis

Outcome of event

Event ID CASEID OUTC COD
126046462 12604646 HO
126046462 12604646 DE

Reactions reported

Event ID CASEID DRUG REC ACT PT
126046462 12604646 Gastric haemorrhage
126046462 12604646 Rectal haemorrhage
126046462 12604646 Shock haemorrhagic

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126046462 12604646 1 20160719 0